This set of 16 cryptic events does not include STMN2 and ARHGAP32, suggesting that these splicing alterations may not be driven by TDP-43 loss of function but instead implied the involvement of neurodegenerative processes shared between FTLD-TDP and AD, potentially extending to other neurodegenerative diseases. This evidence concerns the gene TARDBP and Alzheimer disease.